Jilin Aodong Pharmaceutical Group Co Ltd (000623) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.004x

Based on the latest financial reports, Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a cash flow conversion efficiency ratio of 0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥112.12 Million ≈ $16.41 Million USD) by net assets (CN¥30.82 Billion ≈ $4.51 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Jilin Aodong Pharmaceutical Group Co Ltd for the company's overall valuation and market capitalisation.

Jilin Aodong Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Jilin Aodong Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jilin Aodong Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jilin Aodong Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Explore Jilin Aodong Pharmaceutical Group Co Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Mr D I Y Group M Bhd KLSE:5296	0.142x
Maximus Inc NYSE:MMS	-0.103x
Huada Automotive Tech Corp Ltd SHG:603358	-0.010x
Hybio Pharmaceutical SHE:300199	0.177x
Walvax BioTech SHE:300142	-0.005x
FS KKR Capital Corp NYSE:FSK	-0.002x
PENNON GROUP PLC UNS.ADR2 F:3PN0	N/A
Provident Financial Services Inc NYSE:PFS	0.041x

Annual Cash Flow Conversion Efficiency for Jilin Aodong Pharmaceutical Group Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Jilin Aodong Pharmaceutical Group Co Ltd from 1998 to 2025. View Jilin Aodong Pharmaceutical Group Co Ltd (000623) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥30.89 Billion ≈ $4.52 Billion	CN¥272.26 Million ≈ $39.84 Million	0.009x	+333.92%
2024-12-31	CN¥29.28 Billion ≈ $4.28 Billion	CN¥59.48 Million ≈ $8.70 Million	0.002x	-17.92%
2023-12-31	CN¥27.50 Billion ≈ $4.02 Billion	CN¥68.06 Million ≈ $9.96 Million	0.002x	-84.62%
2022-12-31	CN¥26.34 Billion ≈ $3.85 Billion	CN¥423.86 Million ≈ $62.02 Million	0.016x	+24.04%
2021-12-31	CN¥25.04 Billion ≈ $3.66 Billion	CN¥324.85 Million ≈ $47.54 Million	0.013x	-21.81%
2020-12-31	CN¥23.53 Billion ≈ $3.44 Billion	CN¥390.41 Million ≈ $57.13 Million	0.017x	-1.86%
2019-12-31	CN¥22.44 Billion ≈ $3.28 Billion	CN¥379.46 Million ≈ $55.53 Million	0.017x	+3.32%
2018-12-31	CN¥21.24 Billion ≈ $3.11 Billion	CN¥347.64 Million ≈ $50.87 Million	0.016x	+30.88%
2017-12-31	CN¥20.51 Billion ≈ $3.00 Billion	CN¥256.49 Million ≈ $37.53 Million	0.013x	-29.31%
2016-12-31	CN¥18.87 Billion ≈ $2.76 Billion	CN¥333.81 Million ≈ $48.85 Million	0.018x	-19.85%
2015-12-31	CN¥17.58 Billion ≈ $2.57 Billion	CN¥388.03 Million ≈ $56.78 Million	0.022x	-3.28%
2014-12-31	CN¥12.66 Billion ≈ $1.85 Billion	CN¥288.83 Million ≈ $42.26 Million	0.023x	+25.87%
2013-12-31	CN¥11.10 Billion ≈ $1.62 Billion	CN¥201.22 Million ≈ $29.44 Million	0.018x	-35.10%
2012-12-31	CN¥9.75 Billion ≈ $1.43 Billion	CN¥272.40 Million ≈ $39.86 Million	0.028x	+134.54%
2011-12-31	CN¥9.09 Billion ≈ $1.33 Billion	CN¥108.30 Million ≈ $15.85 Million	0.012x	-50.47%
2010-12-31	CN¥7.25 Billion ≈ $1.06 Billion	CN¥174.22 Million ≈ $25.49 Million	0.024x	-25.95%
2009-12-31	CN¥6.56 Billion ≈ $959.99 Million	CN¥213.03 Million ≈ $31.17 Million	0.032x	-28.95%
2008-12-31	CN¥5.14 Billion ≈ $752.55 Million	CN¥235.03 Million ≈ $34.39 Million	0.046x	-41.87%
2007-12-31	CN¥4.89 Billion ≈ $716.08 Million	CN¥384.69 Million ≈ $56.29 Million	0.079x	-2.34%
2006-12-31	CN¥2.34 Billion ≈ $341.74 Million	CN¥187.99 Million ≈ $27.51 Million	0.080x	-0.09%
2005-12-31	CN¥1.69 Billion ≈ $247.45 Million	CN¥136.26 Million ≈ $19.94 Million	0.081x	-39.83%
2004-12-31	CN¥1.63 Billion ≈ $238.80 Million	CN¥218.53 Million ≈ $31.98 Million	0.134x	+22.53%
2003-12-31	CN¥1.35 Billion ≈ $197.69 Million	CN¥147.65 Million ≈ $21.61 Million	0.109x	+3137.16%
2002-12-31	CN¥1.27 Billion ≈ $186.07 Million	CN¥-4.58 Million ≈ $-669.59K	-0.004x	-103.06%
2001-12-31	CN¥1.18 Billion ≈ $172.57 Million	CN¥138.76 Million ≈ $20.31 Million	0.118x	+68.14%
2000-12-31	CN¥1.10 Billion ≈ $161.09 Million	CN¥77.04 Million ≈ $11.27 Million	0.070x	-55.67%
1999-12-31	CN¥697.92 Million ≈ $102.13 Million	CN¥110.18 Million ≈ $16.12 Million	0.158x	+414.44%
1998-12-31	CN¥615.37 Million ≈ $90.05 Million	CN¥-30.90 Million ≈ $-4.52 Million	-0.050x	--

About Jilin Aodong Pharmaceutical Group Co Ltd

SHE:000623 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.04 Billion

CN¥20.81 Billion CNY

Market Cap Rank

#4876 Global

#814 in China

Share Price

CN¥17.40

Change (1 day)

-1.02%

52-Week Range

CN¥16.52 - CN¥21.82

All Time High

CN¥24.39